Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2793021000168112 | Synagis (palivizumab 50 mg / 0.5 mL) injection, 0.5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2793031000168110 | Synagis 50 mg/0.5 mL injection, 0.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | Is a | palivizumab 50 mg / 0.5 mL injection, 0.5 mL vial (medicinal product unit of use) | true | Inferred relationship | Some | ||
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | Is a | Synagis | true | Inferred relationship | Some | ||
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | has unit of use | vial | true | Inferred relationship | Some | 722693639 | |
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | has Australian BoSS | palivizumab | true | Inferred relationship | Some | 722693638 | |
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | has intended active ingredient | palivizumab | true | Inferred relationship | Some | 722693638 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | has TPUU | True | Synagis 50 mg/0.5 mL injection, 0.5 mL vial | Inferred relationship | Some | 1 |
| Synagis 50 mg/0.5 mL injection, 0.5 mL vial | has TPUU | True | Synagis 50 mg/0.5 mL injection, 0.5 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR